Skip to content
OpenCapital
Get started

Bio-Techne TECH Diagnostics And Spatial Biology — Operating Income

Other segment segments

Protein Sciences
$100M-3.8%

Similar metrics at other companies

Agilent Technologies logo
ADiagnostics and Genomics — Operating Income (Loss)
$94M-6.9%
Agilent Technologies logo
ALife Sciences and Applied Markets — Operating Income (Loss)
$233M-2.9%
Agilent Technologies logo
ALife Sciences and Diagnostics Markets — Income from operations
$161M+24.8%
Chart Industries logo
GTLSBiomedical — Operating Income
$11.11M+186%
Revvity logo
RVTYDiagnostics — Segment operating income
$76.12M+2.8%
ROP
ROPMedical And Scientific Imaging — Operating Income
$110.48M+17.6%

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$9.07B-11.8%
Enterprise value$9.15B-13.6%
P/E60.6×+13.6×
P/S7.5×-1.0×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Techne's diagnostics and spatial biology — operating income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Techne's diagnostics and spatial biology — operating income?
Bio-Techne (TECH) reported diagnostics and spatial biology — operating income of $10.32M in Q1 2026.
How has Bio-Techne's diagnostics and spatial biology — operating income changed year-over-year?
Bio-Techne's diagnostics and spatial biology — operating income increased by 22.5% year-over-year, from $8.42M to $10.32M.
What is the long-term trend for Bio-Techne's diagnostics and spatial biology — operating income?
Over 2 years (2023 to 2025), Bio-Techne's diagnostics and spatial biology — operating income has grown at a -29.6% compound annual growth rate (CAGR), from $43.04M to $21.32M.
What does diagnostics and spatial biology — operating income mean?
The profit or loss generated by the segment's core business operations.
How do you interpret diagnostics and spatial biology — operating income?
Higher operating income indicates better profitability and operational efficiency.
How does diagnostics and spatial biology — operating income compare across companies?
Standard segment-level profitability metric used in financial reporting.